WI
BBP icon

WBI Investments’s Virtus Biotech ETF BBP Stock Holding History

WBI Investments’s Portfolio BBP Stock Details BBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.61M Buy
16,756
+862
+5% +$75K 0.4% 65
2026
Q1 		$1.32M Buy
+15,894
New +$1.31M 0.36% 60

Other funds holding BBP

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
PCIA
Prime Capital Investment Advisors Overland Park, Kansas $10.3B AUM 25.54% 1-Year Est. Return

WBI Investments's BBP Position: Q2 2026 in Review

WBI Investments increased its Virtus Biotech ETF (BBP) stake by 5.4% in Q2 2026, buying an estimated $75K and bringing the position to 16,756 shares worth $1.61M. The position accounts for 0.4% of the portfolio, ranked #65.

WBI Investments first reported a position in BBP in Q1 2026 and has held it in 2 quarters since. 25 funds tracked by Wall St. Rank hold BBP as of Q2 2026.

  • WBI Investments held 16,756 shares of Virtus Biotech ETF worth $1.61M as of Q2 2026.
  • WBI Investments bought 862 Virtus Biotech ETF shares in Q2 2026, an estimated $75K.
  • Virtus Biotech ETF made up 0.4% of WBI Investments's portfolio in Q2 2026, its #65 holding.
  • WBI Investments first reported a position in Virtus Biotech ETF in Q1 2026 and has held it in 2 quarters since.
  • 25 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q2 2026.

Based on WBI Investments's 13F filing for Q2 2026, filed 11 Aug 2026.